Hisamitsu Pharmaceutical Co., Inc.

    Jurisdiction
    Japan
    LEI
    5299006QL3IBQ4CN7E12
    ISIN
    JP3784600003 (4530.T)
    Sectors
    1. Healthcare
    2. Medical - Pharmaceuticals

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    €2.45 813.7% overvalued
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €851.07M
    Gross margin
    56.4%
    EBIT
    €93.78M
    EBIT margin
    11.0%
    Net income
    €87.16M
    Net margin
    10.2%

    Statement period: - (published )

    Dividends

    Last dividend amount
    ¥45.00
    Ex date
    Payment date

    Add to watchlist

    Notifications